DiaMedica Therapeutics Inc (DMAC)
3.00
+0.37
(+14.07%)
USD |
NASDAQ |
May 03, 16:00
3.005
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Price to Book Value: 2.230 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.230 |
| May 02, 2024 | 1.955 |
| May 01, 2024 | 1.926 |
| April 30, 2024 | 1.881 |
| April 29, 2024 | 1.926 |
| April 26, 2024 | 1.911 |
| April 25, 2024 | 1.881 |
| April 24, 2024 | 1.821 |
| April 23, 2024 | 1.799 |
| April 22, 2024 | 1.866 |
| April 19, 2024 | 1.777 |
| April 18, 2024 | 1.851 |
| April 17, 2024 | 1.933 |
| April 16, 2024 | 1.762 |
| April 15, 2024 | 1.777 |
| April 12, 2024 | 1.807 |
| April 11, 2024 | 1.888 |
| April 10, 2024 | 1.970 |
| April 09, 2024 | 2.015 |
| April 08, 2024 | 2.067 |
| April 05, 2024 | 2.216 |
| April 04, 2024 | 2.193 |
| April 03, 2024 | 2.082 |
| April 02, 2024 | 2.030 |
| April 01, 2024 | 2.030 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.059 |
| March 27, 2024 | 1.970 |
| March 26, 2024 | 2.022 |
| March 25, 2024 | 1.992 |
| March 22, 2024 | 2.044 |
| March 21, 2024 | 2.000 |
| March 20, 2024 | 2.059 |
| March 19, 2024 | 2.096 |
| March 18, 2024 | 2.119 |
| March 15, 2024 | 2.253 |
| March 14, 2024 | 2.171 |
| March 13, 2024 | 2.156 |
| March 12, 2024 | 2.149 |
| March 11, 2024 | 2.163 |
| March 08, 2024 | 2.275 |
| March 07, 2024 | 2.282 |
| March 06, 2024 | 2.245 |
| March 05, 2024 | 2.305 |
| March 04, 2024 | 2.383 |
| March 01, 2024 | 2.282 |
| February 29, 2024 | 2.230 |
| February 28, 2024 | 2.253 |
| February 27, 2024 | 2.208 |
| February 26, 2024 | 2.111 |
| February 23, 2024 | 2.104 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8414
Minimum
Sep 26 2022
10.46
Maximum
Feb 21 2020
3.346
Average
2.469
Median
Jun 04 2019
Price to Book Value Benchmarks
| NextCure Inc | 0.3731 |
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.187 |
Price to Book Value Related Metrics
| Price | 3.00 |
| Earnings Yield | -20.67% |
| Market Cap | 113.87M |